Dicerna Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch DRNA and buy or sell other stocks, options, and ETFs commission-free!

About DRNA

Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. 

CEO
Douglas M. Fambrough, III, PhD
CEODouglas M. Fambrough, III, PhD
Employees
Employees
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2006
Founded2006
Employees
Employees

DRNA Key Statistics

Market cap
2.97B
Market cap2.97B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.20M
Average volume3.20M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$40.14
52 Week high$40.14
52 Week low
$19.06
52 Week low$19.06

DRNA Earnings

-$0.53
-$0.22
$0.10
$0.41
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.